Match!

Sustained Remission with Vedolizumab in Patients with Moderately to Severely Active Ulcerative Colitis: A Gemini 1 Post hoc Analysis of Week 14 Remitters

Published on Apr 1, 2017in Gastroenterology19.23
· DOI :10.1016/S0016-5085(17)32155-8
B. Bokemeyer18
Estimated H-index: 18
,
Andreas Stallmach42
Estimated H-index: 42
+ 9 AuthorsBrian G. Feagan94
Estimated H-index: 94
Cite
  • References (0)
  • Citations (0)
Cite
References0
Newest
Cited By0
Newest
View next paperSa1772 - Sustained Clinical Remission with Vedolizumab in Moderateto-Severe Crohn's Disease: A Gemini 2 Post HOC Analysis of Week 14 Remitters